FTO Upregulates GLG1通过m6进行表达甲基化修改以促进胃癌细胞迁移和入侵
Xiaofeng Deng1, Yongjun Hu1, Xin Yang1
1Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
脂肪质量和与肥胖相关的蛋白质 (FTO) 通过通过m6A修饰增加戈尔吉糖蛋白1 (GLG1) 水平,促进胃癌 (GC) 转移. 准FTO和GLG1可能提供新的胃癌治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 胃癌 (GC) 由于其转移性质,具有晚期诊断和不良预后.
- 脂肪质量和与肥胖相关的蛋白质 (FTO),一种N6-甲基氨酸 (m6A) 脱甲基酶,影响GC发育.
- 戈尔吉糖蛋白1 (GLG1) 在GC上调,与晚期疾病阶段和转移有关.
研究的目的:
- 在GC中识别FTO规范的因素.
- 研究GLG1在GC进展和转移中的作用.
- 阐明FTO在GC中的GLG1表达的调节机制.
主要方法:
- 在GC组织和细胞系中分析GLG1表达.
- 在体外和体外对GLG1和FTO进行了淘汰试验.
- 评估GC细胞的攻击性,入侵性和转移性.
- 通过m6A修饰来研究FTO对GLG1mRNA稳定性的影响.
主要成果:
- 在GC中GLG1的表达显著上调,与晚期,淋巴结转移和糟糕的生存结果相关.
- GLG1促进GC细胞的攻击性,入侵和转移.
- FTO积极调节GLG1表达,通过mRNA稳定性影响GC细胞表型.
- FTO敲击降低了GLG1水平,并减轻了GC细胞的攻击性.
结论:
- FTO通过m6A甲基化调节GLG1表达,有助于GC细胞的攻击性.
- FTO-GLG1相互作用代表了GC中一种新的转录后调节机制.
- GLG1和FTO是缓解GC进展和转移的潜在治疗点.
更多相关视频
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
GPCRs Regulate Adenylyl Cylase Activity
Mitogens and the Cell Cycle
Cancer Cell Migration through Invadopodia
Activation and Inactivation of G Proteins
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
